1,4-phenylenebis(methylene)selenocyanate has been researched along with Prostatic Intraepithelial Neoplasia in 1 studies
1,4-phenylenebis(methylene)selenocyanate: structure given in first source; inhibits DMBA-induced carcinogenesis by inhibiting DMBA-DNA adduct formation
Prostatic Intraepithelial Neoplasia: A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The long latency of prostate cancer development provides an opportunity to intervene with agents of known mechanisms at various stages of disease progression." | 1.36 | 1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells. ( El-Bayoumy, K; Facompre, ND; Pinto, JT; Sinha, R; Sun, YW, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Facompre, ND | 1 |
| El-Bayoumy, K | 1 |
| Sun, YW | 1 |
| Pinto, JT | 1 |
| Sinha, R | 1 |
1 other study available for 1,4-phenylenebis(methylene)selenocyanate and Prostatic Intraepithelial Neoplasia
| Article | Year |
|---|---|
1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.
Topics: Androgen Antagonists; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Evaluation, Preclin | 2010 |